The Potential of Stem Cells and Stem Cell-Derived Exosomes in Treating Cardiovascular Diseases

Overview

Journal J Cardiovasc Transl Res

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2018 Mar 12

PMID 29525884

Citations 15

Authors

Jing Ni

Yuxi Sun

Zheng Liu

Affiliations

Soon will be listed here.

Abstract

In recent years, the cardiac protective mechanisms of stem cells have become a research focus. Increasing evidence has suggested that stem cells release vesicles, including exosomes and micro-vesicles. The content of these vesicles relies on an extracellular stimulus, and active ingredients are extensively being studied. Previous studies have confirmed that stem cell-derived exosomes have a cardiac protective function similar to that of stem cells, and promote angiogenesis, decrease apoptosis, and respond to stress. Compared to stem cells, exosomes are more stable without aneuploidy and immune rejection, and may be a promising and effective therapy for cardiovascular diseases. In this review, the biological functions and molecular mechanisms of stem cells and stem cell-derived exosomes are discussed.

Citing Articles

Cathepsin K inhibition promotes efficient differentiation of human embryonic stem cells to mature cardiomyocytes by mediating glucolipid metabolism and cellular energy homeostasis.

Wang Y, Cui Y, Liu X, Liang S, Zhong L, Guo R Stem Cell Res Ther. 2025; 16(1):118.

PMID: 40045408 PMC: 11883997. DOI: 10.1186/s13287-025-04231-7.

Diabetic Cardiomyopathy: Role of Cell Death, Exosomes, Fibrosis and Epicardial Adipose Tissue.

Galeone A, Annicchiarico A, Buccoliero C, Barile B, Luciani G, Onorati F Int J Mol Sci. 2024; 25(17).

PMID: 39273428 PMC: 11395197. DOI: 10.3390/ijms25179481.

Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight.

Ali S, Zulfiqar M, Summer M, Arshad M, Noor S, Nazakat L Mol Biol Rep. 2024; 51(1):904.

PMID: 39133413 DOI: 10.1007/s11033-024-09814-w.

BMSCs-derived Exosome CISH Alleviates Myocardial Infarction by Inactivating the NF-κB Pathway to Stimulate Macrophage M2 Polarization.

Ouyang M, Yang Y, Yu G, Zhao J, Peng Y Cardiovasc Toxicol. 2024; 24(4):422-434.

PMID: 38512651 DOI: 10.1007/s12012-024-09847-4.

Role of Epicardial Adipose Tissue Secretome on Cardiovascular Diseases.

Leo S, Tremoli E, Ferroni L, Zavan B Biomedicines. 2023; 11(6).

PMID: 37371748 PMC: 10296291. DOI: 10.3390/biomedicines11061653.

References

Wang W, Chen X, Houser S, Zeng C . Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease. Clin Sci (Lond). 2013; 125(7):319-27. PMC: 3744218. DOI: 10.1042/CS20130019. View

Viegas C, Rafael M, Enriquez J, Teixeira A, Vitorino R, Luis I . Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Arterioscler Thromb Vasc Biol. 2014; 35(2):399-408. DOI: 10.1161/ATVBAHA.114.304823. View

Yu B, Kim H, Gong M, Wang J, Millard R, Wang Y . Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol. 2015; 182:349-60. PMC: 4382384. DOI: 10.1016/j.ijcard.2014.12.043. View

Pereg D, Cohen K, Mosseri M, Berlin T, Steinberg D, Ellis M . Incidence and Expression of Circulating Cell Free p53-Related Genes in Acute Myocardial Infarction Patients. J Atheroscler Thromb. 2015; 22(9):981-98. DOI: 10.5551/jat.29223. View

van Berlo J, Kanisicak O, Maillet M, Vagnozzi R, Karch J, Lin S . c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014; 509(7500):337-41. PMC: 4127035. DOI: 10.1038/nature13309. View

Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T . Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013; 165(2):77-84. DOI: 10.1016/j.jbiotec.2013.03.013. View

Hutcheson J, Goettsch C, Bertazzo S, Maldonado N, Ruiz J, Goh W . Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques. Nat Mater. 2016; 15(3):335-43. PMC: 4767675. DOI: 10.1038/nmat4519. View

FRIEDENSTEIN A, PETRAKOVA K, Kurolesova A, Frolova G . Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968; 6(2):230-47. View

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

10.

Fukata M, Ishikawa F, Najima Y, Yamauchi T, Saito Y, Takenaka K . Contribution of bone marrow-derived hematopoietic stem/progenitor cells to the generation of donor-marker⁺ cardiomyocytes in vivo. PLoS One. 2013; 8(5):e62506. PMC: 3647070. DOI: 10.1371/journal.pone.0062506. View

11.

Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S . Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008; 118(5):498-506. DOI: 10.1161/CIRCULATIONAHA.108.769562. View

12.

Tzahor E, Poss K . Cardiac regeneration strategies: Staying young at heart. Science. 2017; 356(6342):1035-1039. PMC: 5614484. DOI: 10.1126/science.aam5894. View

13.

van der Pol E, Coumans F, Grootemaat A, Gardiner C, Sargent I, Harrison P . Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014; 12(7):1182-92. DOI: 10.1111/jth.12602. View

14.

Karimzadeh F, Opas M . Calreticulin Is Required for TGF-β-Induced Epithelial-to-Mesenchymal Transition during Cardiogenesis in Mouse Embryonic Stem Cells. Stem Cell Reports. 2017; 8(5):1299-1311. PMC: 5425659. DOI: 10.1016/j.stemcr.2017.03.018. View

15.

Riolobos L, Hirata R, Turtle C, Wang P, Gornalusse G, Zavajlevski M . HLA engineering of human pluripotent stem cells. Mol Ther. 2013; 21(6):1232-41. PMC: 3677304. DOI: 10.1038/mt.2013.59. View

16.

Padin-Iruegas M, Misao Y, Davis M, Segers V, Esposito G, Tokunou T . Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation. 2009; 120(10):876-87. PMC: 2913250. DOI: 10.1161/CIRCULATIONAHA.109.852285. View

17.

Golpanian S, Wolf A, Hatzistergos K, Hare J . Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev. 2016; 96(3):1127-68. PMC: 6345247. DOI: 10.1152/physrev.00019.2015. View

18.

Zhang Y, Mignone J, MacLellan W . Cardiac Regeneration and Stem Cells. Physiol Rev. 2015; 95(4):1189-204. PMC: 4600953. DOI: 10.1152/physrev.00021.2014. View

19.

Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R . Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001; 104(9):1046-52. DOI: 10.1161/hc3501.093817. View

20.

Choi W, Gemberling M, Wang J, Holdway J, Shen M, Karlstrom R . In vivo monitoring of cardiomyocyte proliferation to identify chemical modifiers of heart regeneration. Development. 2013; 140(3):660-6. PMC: 3561784. DOI: 10.1242/dev.088526. View